Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PAMELA RUDOLPH CAMPISI

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1396003760
CMS profile
10944018
Location
VERO BEACH, FL

General Payments · PY2021–2024

$3,072.91

  • Reported across 114 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,067.51

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,067.51 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $278.89 11
Alkermes, Inc. $277.27 6
ABBVIE INC. $163.09 7
E.R. Squibb & Sons, L.L.C. $120.41 1
Otsuka America Pharmaceutical, Inc. $103.93 5
ITI, Inc. $80.24 2
Braeburn Inc. $26.15 1
Supernus Pharmaceuticals, Inc. $17.53 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $924.28 50
PY2022 $529.61 16
PY2023 $551.51 14
PY2024 $1,067.51 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.39 07/24/2024 Food and Beverage Undisputed 01/23/2026 1106872055 CMS
ABBVIE INC. $17.09 08/27/2024 Food and Beverage Undisputed 01/23/2026 1106872057 CMS
ABBVIE INC. $25.53 09/24/2024 Food and Beverage Undisputed 01/23/2026 1106872059 CMS
ABBVIE INC. $20.59 10/15/2024 Food and Beverage Undisputed 01/23/2026 1106872061 CMS
ABBVIE INC. $29.71 11/13/2024 Food and Beverage Undisputed 01/23/2026 1106872063 CMS
ABBVIE INC. $7.18 11/20/2024 Food and Beverage Undisputed 01/23/2026 1106872065 CMS
ABBVIE INC. $30.60 12/11/2024 Food and Beverage Undisputed 01/23/2026 1106872067 CMS
Alkermes, Inc. $13.38 01/17/2024 Food and Beverage Undisputed 01/23/2026 1120475540 CMS
Alkermes, Inc. $14.67 06/18/2024 Food and Beverage Undisputed 01/23/2026 1120475542 CMS
Alkermes, Inc. $117.10 07/23/2024 Food and Beverage Undisputed 01/23/2026 1120475544 CMS
Alkermes, Inc. $15.36 09/17/2024 Food and Beverage Undisputed 01/23/2026 1120475546 CMS
Alkermes, Inc. $112.88 10/16/2024 Food and Beverage Undisputed 01/23/2026 1120475548 CMS
Alkermes, Inc. $3.88 11/15/2024 Food and Beverage Undisputed 01/23/2026 1120475550 CMS
Braeburn Inc. $26.15 09/11/2024 Food and Beverage Undisputed 01/23/2026 1125620338 CMS
E.R. Squibb & Sons, L.L.C. $120.41 12/19/2024 Food and Beverage Undisputed 01/23/2026 1101513723 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.33 09/11/2024 Food and Beverage Undisputed 01/23/2026 1143396962 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $61.91 10/03/2024 Food and Beverage Undisputed 01/23/2026 1143396966 CMS
Janssen Pharmaceuticals, Inc $7.64 01/10/2024 Food and Beverage Undisputed 01/23/2026 1077980208 CMS
Janssen Pharmaceuticals, Inc $23.92 02/20/2024 Food and Beverage Undisputed 01/23/2026 1077980194 CMS
Janssen Pharmaceuticals, Inc $6.14 03/20/2024 Food and Beverage Undisputed 01/23/2026 1077980182 CMS
Janssen Pharmaceuticals, Inc $20.57 07/10/2024 Food and Beverage Undisputed 01/23/2026 1077980318 CMS
Janssen Pharmaceuticals, Inc $19.48 09/10/2024 Food and Beverage Undisputed 01/23/2026 1077980252 CMS
Janssen Pharmaceuticals, Inc $7.21 09/24/2024 Food and Beverage Undisputed 01/23/2026 1077980316 CMS
Janssen Pharmaceuticals, Inc $8.27 10/08/2024 Food and Beverage Undisputed 01/23/2026 1077980258 CMS
Janssen Pharmaceuticals, Inc $12.32 10/22/2024 Food and Beverage Undisputed 01/23/2026 1077980300 CMS
Janssen Pharmaceuticals, Inc $150.00 10/23/2024 Food and Beverage Undisputed 01/23/2026 1077980268 CMS
Janssen Pharmaceuticals, Inc $11.51 11/19/2024 Food and Beverage Undisputed 01/23/2026 1077980216 CMS
Janssen Pharmaceuticals, Inc $11.83 12/17/2024 Food and Beverage Undisputed 01/23/2026 1077980294 CMS
Otsuka America Pharmaceutical, Inc. $28.62 03/01/2024 Food and Beverage Undisputed 01/23/2026 1119039277 CMS
Otsuka America Pharmaceutical, Inc. $19.73 05/15/2024 Food and Beverage Undisputed 01/23/2026 1119039279 CMS
Otsuka America Pharmaceutical, Inc. $22.22 08/07/2024 Food and Beverage Undisputed 01/23/2026 1119039281 CMS
Otsuka America Pharmaceutical, Inc. $14.45 08/21/2024 Food and Beverage Undisputed 01/23/2026 1119039283 CMS
Otsuka America Pharmaceutical, Inc. $18.91 10/30/2024 Food and Beverage Undisputed 01/23/2026 1119039285 CMS
Supernus Pharmaceuticals, Inc. $17.53 07/04/2024 Food and Beverage Undisputed 01/23/2026 1147889517 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.